Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | MAPT | P10636 | 4/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | SLC6A1 | P30531 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.34 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TYMP | P19971 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25849146 | 0.93 | EP300 (0.36) | ALDH1A1SLC6A1KMT2ASLC6A11CYP2J2 | |
| SCHEMBL25849145 | 0.93 | EP300 (0.36) | ALDH1A1SLC6A1KMT2ASLC6A11CYP2J2 | |
| SCHEMBL6801773 | 0.91 | PDPK1 (0.36) | ALDH1A1MAPTSLC6A1KMT2ASLC6A11 | |
| SCHEMBL6791347 | 0.90 | SLC6A1 (0.35) | ALDH1A1MAPTSLC6A1KMT2ALMNA | |
| SCHEMBL6796641 | 0.83 | TYMP (0.35) | ALDH1A1MAPTSLC6A1KMT2ALMNA | |
| SCHEMBL23996822 | 0.81 | MAPT (0.36) | ALDH1A1MAPTPOLBSLC6A1KMT2A | |
| SCHEMBL25849147 | 0.79 | ALDH1A1 (0.38) | ALDH1A1POLBLMNASMN1; SMN2CYP3A4 | |
| SCHEMBL25849142 | 0.79 | CNR2 (0.37) | POLBSLC6A1L3MBTL1SLC6A11SMN1; SMN2 | |
| SCHEMBL6797097 | 0.79 | EDNRA (0.40) | ALDH1A1SLC6A1KMT2ALMNASLC6A11 | |
| SCHEMBL6797102 | 0.79 | EDNRA (0.40) | ALDH1A1SLC6A1KMT2ALMNASLC6A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230203474-A1 | COMPOUND, SOLID CARRIER INCLUDING THE SAME AND METHOD FOR PREPARING NUCLEIC ACID | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2023-06-29 | — | — | US | disclosed |
| US-20230203474-A1 | COMPOUND, SOLID CARRIER INCLUDING THE SAME AND METHOD FOR PREPARING NUCLEIC ACID | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2023-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230203474-A1 | COMPOUND, SOLID CARRIER INCLUDING THE SAME AND METHOD FOR PREPARING NUCLEIC ACID | SNRPA, NSUN2, POLRMT | ALDH1A1 2601/4885MAPT 3002/4885POLB 54/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.